High-Flow Nasal Cannula Therapy for the Management of Hypoxaemic Respiratory Failure in Patients with SARS-CoV-2 Pneumonia: An Observational Cohort Study

Autor: Gallardo-Rincón H, Chavarria Ap, Juárez Lm, Wyssmann Rvá, Avendaño Ma, Cerda MLRdl, Gascon Jl, Bello Hh, Benavides Rv, Vazquez Rrv, Castañeda Lm, Lezama Es, Luis Alberto Martinez-Juarez, Navarro Mg, Tapia-Conyer R, Gonzalez Ler, Ortiz Bs

Publikováno v: SSRN Electronic Journal.

Background: The utility of high-flow nasal cannula (HFNC) to reduce the need for invasive mechanical ventilation (IMV) in patients with hypoxaemic respiratory failure due to COVID-19 is poorly understood. Methods: We designed a prospective observatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86b0c74fdb2e846bac6d63ae83dbdc70
https://doi.org/10.2139/ssrn.3793561

Impact of preemptive hospitalization on health outcomes at the temporary COVID-19 hospital in Mexico City: a prospective observational study.

Autor: Vazquez RRV; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Gallardo-Rincón H; Mexico Carlos Slim Foundation, Lago Zurich 245, Presa Falcon Building (Floor 20), Miguel Hidalgo, Mexico City 11529, Mexico., Lomelín-Gascon J; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Ville Benavides R; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Juárez LM; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Bello HH; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Castañeda LM; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Chavarria AP; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Castillo PE; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Gonzalez LER; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Avendaño MA; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Berlanga ST; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Loza RAR; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Wyssmann RVÁ; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Lezama ES; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Romero AG; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Ortega MDN; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Acosta LV; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Schotman AC; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Montoya JB; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Rodriguez AG; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Ramos LMB; Temporary COVID-19 Hospital, Hipódromo de las Américas, Miguel Hidalgo, Mexico City, Mexico., Martinez-Juarez LA; Carlos Slim Foundation, Miguel Hidalgo, Mexico City, Mexico., Saucedo-Martínez R; Carlos Slim Foundation, Miguel Hidalgo, Mexico City, Mexico., Montoya A; Carlos Slim Foundation, Miguel Hidalgo, Mexico City, Mexico., Tapia-Conyer R; Carlos Slim Foundation, Miguel Hidalgo, Mexico City, Mexico.

Publikováno v: Therapeutic advances in infectious disease [Ther Adv Infect Dis] 2021 Aug 27; Vol. 8, pp. 20499361211040325. Date of Electronic Publication: 2021 Aug 27 (Print Publication: 2021).